SE8403912D0 - PHARMACEUTICAL KIT OR COMPOSITION - Google Patents

PHARMACEUTICAL KIT OR COMPOSITION

Info

Publication number
SE8403912D0
SE8403912D0 SE8403912A SE8403912A SE8403912D0 SE 8403912 D0 SE8403912 D0 SE 8403912D0 SE 8403912 A SE8403912 A SE 8403912A SE 8403912 A SE8403912 A SE 8403912A SE 8403912 D0 SE8403912 D0 SE 8403912D0
Authority
SE
Sweden
Prior art keywords
physiologically acceptable
composition
pharmaceutical kit
drug
carrier
Prior art date
Application number
SE8403912A
Other languages
Swedish (sv)
Inventor
K-E Arfors
B Gerdin
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE8403912A priority Critical patent/SE8403912D0/en
Publication of SE8403912D0 publication Critical patent/SE8403912D0/en
Priority to CA000487656A priority patent/CA1246449A/en
Priority to JP50341185A priority patent/JPS61502821A/en
Priority to AU46713/85A priority patent/AU4671385A/en
Priority to EP19850903893 priority patent/EP0188595A1/en
Priority to PCT/SE1985/000296 priority patent/WO1986000812A1/en

Links

Abstract

A drug kit or drug composition for use in preventing and treating ischaemic cell damage comprises: a) at least one plasma volume expander; b) at least one low molecular, physiologically acceptable hydroxyl radical scavenger; c) at least one physiologically acceptable and water-soluble magnesium salt; and d) at least one organic compound active as a calcium blocking agent dissolved in a carrier, either per se or in one or several combinations.
SE8403912A 1984-07-30 1984-07-30 PHARMACEUTICAL KIT OR COMPOSITION SE8403912D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE8403912A SE8403912D0 (en) 1984-07-30 1984-07-30 PHARMACEUTICAL KIT OR COMPOSITION
CA000487656A CA1246449A (en) 1984-07-30 1985-07-29 Drug kit or drug composition for ischaemic damage
JP50341185A JPS61502821A (en) 1984-07-30 1985-07-30 drug kit or drug composition
AU46713/85A AU4671385A (en) 1984-07-30 1985-07-30 A drug kit or drug composition
EP19850903893 EP0188595A1 (en) 1984-07-30 1985-07-30 A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereof
PCT/SE1985/000296 WO1986000812A1 (en) 1984-07-30 1985-07-30 A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8403912A SE8403912D0 (en) 1984-07-30 1984-07-30 PHARMACEUTICAL KIT OR COMPOSITION

Publications (1)

Publication Number Publication Date
SE8403912D0 true SE8403912D0 (en) 1984-07-30

Family

ID=20356627

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403912A SE8403912D0 (en) 1984-07-30 1984-07-30 PHARMACEUTICAL KIT OR COMPOSITION

Country Status (6)

Country Link
EP (1) EP0188595A1 (en)
JP (1) JPS61502821A (en)
AU (1) AU4671385A (en)
CA (1) CA1246449A (en)
SE (1) SE8403912D0 (en)
WO (1) WO1986000812A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939146A (en) * 1987-01-29 1990-07-03 Kramer Richard S Method for alleviating ischemic-reperfusion injury
ES2007994A6 (en) * 1988-08-16 1989-07-01 Grino Boira Jose Maria Liquid medium for infusion and preservation of organs.
CH683485A5 (en) * 1990-11-20 1994-03-31 Pasteur Merieux Serums Vacc infusion solutions, preservation and organ perfusion.
WO1994008612A1 (en) * 1992-10-22 1994-04-28 Thomas Peter G New method of protecting central nervous system against damage resulting from cerebrovascular or neuronal compromise
US6265385B1 (en) 1996-01-11 2001-07-24 Topo Target Aps Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy
WO1997025044A1 (en) * 1996-01-11 1997-07-17 Peter Buhl Jensen Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy
US5834178C1 (en) * 1997-07-09 2002-04-23 Univ Wayne State Flush-storage solution for donor organs
US6977140B1 (en) 1998-09-29 2005-12-20 Organ Recovery Systems, Inc. Method for maintaining and/or restoring viability of organs
DE69941362D1 (en) * 1998-09-29 2009-10-15 Organ Recovery Systems Inc DEVICE AND METHOD FOR MAINTAINING AND / OR RESTORING THE VITABILITY OF ORGANS
US6485959B1 (en) 1998-10-07 2002-11-26 Cedars Sinai Medical Center Cell preconditioning and cryopresevation medium
JP2001026536A (en) * 1999-05-10 2001-01-30 Nikken Kasei Kk Radical scavenger
US6492103B1 (en) 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
WO2007105179A1 (en) * 2006-03-15 2007-09-20 Universitat Bern Cardioplegic solution
PT2328593E (en) * 2008-08-22 2015-04-13 Universität Bern Cardioplegic preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2532183C3 (en) * 1975-07-18 1982-03-04 Behringwerke Ag, 3550 Marburg Polyionic isotonic saline solution for the preservation of erythrocytes or for the perfusion and preservation of organs intended for transplantation
CH639270A5 (en) * 1978-12-14 1983-11-15 Koehler Franz Dr Chemie Kg PROTECTIVE SOLUTION FOR HEART AND KIDNEY.
FR2490963B1 (en) * 1980-09-30 1986-04-18 Science Union & Cie NOVEL THERAPEUTIC COMPOSITION WITH ANTI-ISCHEMIC ACTION CONTAINING TRIMETHOXY 2, 3, 4-BENZYL 1-PIPERAZINE
ATE11736T1 (en) * 1980-12-23 1985-02-15 Dr. Franz Koehler Chemie Gmbh HEART AND KIDNEY PROTECTIVE SOLUTION AND PROCESS FOR PRODUCTION.
SE8200252L (en) * 1982-01-18 1983-07-19 Pharmacia Ab PHARMACEUTICAL COMPOSITION
GB8308126D0 (en) * 1983-03-24 1983-05-05 Bloch M Pharmaceutical compositions

Also Published As

Publication number Publication date
WO1986000812A1 (en) 1986-02-13
CA1246449A (en) 1988-12-13
AU4671385A (en) 1986-02-25
JPS61502821A (en) 1986-12-04
EP0188595A1 (en) 1986-07-30

Similar Documents

Publication Publication Date Title
SE8403912D0 (en) PHARMACEUTICAL KIT OR COMPOSITION
ATE59297T1 (en) TOPICAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITION CONTAINING A SILVER COMPOUND AND AN AZOLE.
ATE252081T1 (en) NEW HIV PROTEASE INHIBITORS
NO20014662D0 (en) Methods and Preparations for Treating Solid Tumors
ATE175412T1 (en) HIV PROTEASE INHIBITORS
KR870005637A (en) Drug depot
ATE311227T1 (en) FAST-ACTING, FREEZE-DRIED, ORAL, PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF MIGRAINE
SE8504945L (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANTRACYCLING GYCOSIDES
FI953748A (en) Compounds with both potent calcium antagonist and antioxidant activity and their use as cell protective agents
UY26635A1 (en) SYNERGIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
GR1001503B (en) Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses.
DK0923570T3 (en) Pyridylalkene and pyridylalkynic acid amides as cytostatic and immunosuppressive agents
BR0007589A (en) Cell proliferation inhibitors
AR043071A1 (en) USE OF MACROLIDES FOR THE TREATMENT OF CANCER AND MACULAR DEGENERATION AND A PHARMACEUTICAL COMPOSITION
ECSP930933A (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR PREPARING IT
DE69430385D1 (en) HIV Protease Inhibitors
ATE201823T1 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING HEPARIN
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
UY26514A1 (en) "COMPOSITION FOR THE TREATMENT OF DAMAGED TISSUES".
GB9505082D0 (en) Medicament
NZ336043A (en) Use of COMT inhibitors for preventing diabetic vascular dysfunctions or neuropathy
WO1996000068A3 (en) Combination therapy for hiv infection
IE840977L (en) Pharmaceutical preparations
DE59510583D1 (en) PHARMACEUTICAL COMPOSITION FOR SYSTEMIC TRANSDERMAL ADMINISTRATION WITH THE ACTIVE MORPHINE-6-GLUCURONIDE
BR0014751A (en) Compound, stereoisomer or mixture of stereoisomers, pharmaceutical composition, method of treating a patient in need of antimicrobial treatment, and use of a compound